Hormone therapy before frozen embryo transfer is tied to larger babies but not to differences in early childhood IQ - PsyPost

TomOkay, I want your take on something: Hormone therapy before frozen embryo transfer is tied to larger babies but not to differences in early childhood IQ. Go ahead, tell me what you think.

CarolThe part that bothers me isn’t the baby weight, it’s the word “tied.” A woman walking into her clinic hearing hormone shots might change her child’s brain development would panic, even though the data says the IQ numbers stayed steady. That gap between what the science found and how people will hear it is where the real damage happens.

TomYou’re making my blood pressure spike just thinking about that headline hitting a phone screen at midnight. But here’s the thing—the bigger babies are actually the scary bit, because excess birth weight can lead to immediate delivery complications, yet nobody seems to notice that trade-off while they’re fixated on the phantom risk to their kid’s brain.

CarolCalling it a trade-off misses who actually holds the risk. The mother manages the medication protocol, but the infant has zero control over whether those extra pounds cause trouble during delivery. We’re debating abstract outcomes when the clinical reality is that fetal macrosomia complicates labor for the parent directly.

TomYou're right that the parent takes the physical strain, but ignoring the size factor leaves half the picture dark. We need to know exactly how much heavier these babies get compared to untreated cycles before we start telling women to skip the shots. The IQ safety net doesn't mean we should treat birth weight as a minor footnote.

CarolStopping the treatment based on guesswork puts the pregnancy itself in jeopardy, and that’s a risk no clinician accepts without proof. You don’t get to prioritize delivery comfort over confirmed developmental safety just because the scale reads higher. The medical decision stays anchored to the data we actually have, not our anxiety about the unknown.

TomPinning the whole decision to "confirmed" data ignores that birth weight is a visible, measurable outcome happening in front of us, unlike theoretical long-term risks. The protocol shouldn't stay rigid just because the IQ chart looks clean; adjusting dosage to manage that extra bulk is standard care, not reckless guessing. You're defending the status quo because it's easier than admitting the current shots might need tweaking.

CarolAdjusting dosage without a clear target weight is exactly the kind of untested tinkering that creates new problems faster than it solves old ones. You’re calling it standard care, but in reproductive endocrinology, changing variables mid-cycle without robust trial data is how you end up with unexpected side effects neither parent asked for. Stick to the protocol until there’s actual evidence that lowering the dose shrinks the baby safely.

TomYou’re stuck in the weeds worrying about side effects when the main event is already producing oversized infants every single cycle. The IQ results being stable gives us permission to look at the delivery room, not reason to freeze the entire process in place. Just because a variable hasn’t been fully mapped yet doesn’t mean we have to ignore the baby standing three inches too tall.

CarolYour image of a giant baby proves nothing about the mechanism driving the growth, and assuming a simple dial exists lets your imagination fill the gaps the data left open. Until we understand why the hormones trigger that specific increase, tweaking the dose is just random gambling with a real fetus attached. You keep demanding action on a mystery you refuse to investigate properly.

TomYou’re spinning your wheels on the “why” when the practical fix is sitting right there on the table. I’m not asking for a perfect map of hormone mechanics, just the common sense to adjust the prescription before the next batch of mothers goes through unnecessary C-sections. Stop hiding behind the complexity of the biology and admit that keeping the dose static is a choice, not an inevitability.

CarolYou’re framing a static dose as cowardice, but it’s the only option that keeps the embryo transfer from becoming a coin flip. Telling a woman to lower her hormone levels based on last year’s birth charts isn’t practical care; it’s guessing with her fertility on the line. I’d rather accept a slightly larger baby than gamble on a protocol nobody has tested for safety.

TomCalling it a coin flip flips the logic entirely, since the research explicitly ties the size issue to the therapy itself, not bad luck. You are choosing to live with a known consequence while pretending the alternative is dangerous speculation. That preference sounds more like professional caution masking a fear of having to change things.

CarolBlaming my caution is a deflection tactic that avoids the core problem: we still lack proof that altering the hormonal balance improves outcomes without introducing new complications. The link between therapy and size doesn't automatically grant permission to deviate from established protocols just because the babies are bigger. We need controlled studies showing safe dosage adjustments, not anecdotes driven by delivery room stress.

TomDemanding a full clinical trial before touching a prescription is waiting for perfection in a field where the answer is already visible in the nursery. We know the therapy causes the size, so holding the dose constant is a deliberate choice to prioritize convenience over the mother’s recovery time. You can keep citing missing data all day, but eventually you have to acknowledge that ignoring a proven side effect is its own kind of negligence.

CarolLabeling protocol adherence as negligence twists the meaning of due diligence into something reckless. A known correlation is not a license to alter treatment without knowing the threshold where benefit turns to harm. We protect patients by respecting what the current evidence actually supports, even when the outcome feels uncomfortable.

TomRespect for current evidence stops at the point where that same evidence confirms the therapy creates the problem, so "waiting" just becomes another word for refusing to act on known facts. The only real barrier here is the absence of a safety study for adjusted doses, which means every additional baby born oversized under the old protocol is a preventable cost we chose to pay.